GlobeNewsWire
14 Aug 2026, 12:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Vivos Therapeutics management will provide updates on strategic collaborations and their expected impact on near-term revenue growth and cash burn during today's call. — Details on revenue acceleration and cash runway are the primary drivers of valuation for small-cap medical device companies.
+0.40Vivos Therapeutics is scheduled to release its second quarter 2026 financial results after market close on Friday, August 14, 2026. — Standard earnings releases create short-term volatility but are expected events.
+0.10Which stocks this story touches
The article is a routine announcement scheduling the release of financial results and a conference call.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
GlobeNewsWire
1h ago
